|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of premiums and discounts on marketable securities | |||||
| Stock-based compensation | |||||
| Asset impairment | |||||
| Noncash operating lease expense | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued liabilities and other liabilities | |||||
| Lease liabilities | |||||
| Other long-term liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Sales and maturities of marketable securities | |||||
| Purchases of marketable securities | |||||
| Purchases of property and equipment | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from shares issued under ESPP | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents - beginning of period | |||||
| Cash and cash equivalents - end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
Loading...